Literature DB >> 28736337

TFOS DEWS II Epidemiology Report.

Fiona Stapleton1, Monica Alves2, Vatinee Y Bunya3, Isabelle Jalbert4, Kaevalin Lekhanont5, Florence Malet6, Kyung-Sun Na7, Debra Schaumberg8, Miki Uchino9, Jelle Vehof10, Eloy Viso11, Susan Vitale12, Lyndon Jones13.   

Abstract

The subcommittee reviewed the prevalence, incidence, risk factors, natural history, morbidity and questionnaires reported in epidemiological studies of dry eye disease (DED). A meta-analysis of published prevalence data estimated the impact of age and sex. Global mapping of prevalence was undertaken. The prevalence of DED ranged from 5 to 50%. The prevalence of signs was higher and more variable than symptoms. There were limited prevalence studies in youth and in populations south of the equator. The meta-analysis confirmed that prevalence increases with age, however signs showed a greater increase per decade than symptoms. Women have a higher prevalence of DED than men, although differences become significant only with age. Risk factors were categorized as modifiable/non-modifiable, and as consistent, probable or inconclusive. Asian ethnicity was a mostly consistent risk factor. The economic burden and impact of DED on vision, quality of life, work productivity, psychological and physical impact of pain, are considerable, particularly costs due to reduced work productivity. Questionnaires used to evaluate DED vary in their utility. Future research should establish the prevalence of disease of varying severity, the incidence in different populations and potential risk factors such as youth and digital device usage. Geospatial mapping might elucidate the impact of climate, environment and socioeconomic factors. Given the limited study of the natural history of treated and untreated DED, this remains an important area for future research.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Dry eye disease; Incidence; Natural history; Prevalence; Quality of life; Questionnaire; Risk factor; Societal cost

Mesh:

Year:  2017        PMID: 28736337     DOI: 10.1016/j.jtos.2017.05.003

Source DB:  PubMed          Journal:  Ocul Surf        ISSN: 1542-0124            Impact factor:   5.033


  379 in total

1.  Manganese(III) tetrakis(1-methyl-4-pyridyl) porphyrin, a superoxide dismutase mimetic, reduces disease severity in in vitro and in vivo models for dry-eye disease.

Authors:  Agnė Žiniauskaitė; Symantas Ragauskas; Anita K Ghosh; Rubina Thapa; Anne E Roessler; Peter Koulen; Giedrius Kalesnykas; Jenni J Hakkarainen; Simon Kaja
Journal:  Ocul Surf       Date:  2019-02-23       Impact factor: 5.033

2.  Choosing Core Outcomes for Use in Clinical Trials in Ophthalmology: Perspectives from Three Ophthalmology Outcomes Working Groups.

Authors:  Ian J Saldanha; Jimmy T Le; Sharon D Solomon; Michael X Repka; Esen K Akpek; Tianjing Li
Journal:  Ophthalmology       Date:  2019-01       Impact factor: 12.079

3.  The Dry Eye Assessment and Management (DREAM) extension study - A randomized clinical trial of withdrawal of supplementation with omega-3 fatty acid in patients with dry eye disease.

Authors:  Munira Hussain; Roni M Shtein; Maxwell Pistilli; Maureen G Maguire; Marko Oydanich; Penny A Asbell
Journal:  Ocul Surf       Date:  2019-08-16       Impact factor: 5.033

4.  Prevalence of dry eye in video display terminal users: a cross-sectional Caucasian study in Italy.

Authors:  Gemma Caterina Maria Rossi; Luigia Scudeller; Federica Bettio; Gian Maria Pasinetti; Paolo Emilio Bianchi
Journal:  Int Ophthalmol       Date:  2018-06-07       Impact factor: 2.031

5.  n-3 Fatty Acid Supplementation for the Treatment of Dry Eye Disease.

Authors:  Penny A Asbell; Maureen G Maguire; Maxwell Pistilli; Gui-shuang Ying; Loretta B Szczotka-Flynn; David R Hardten; Meng C Lin; Roni M Shtein
Journal:  N Engl J Med       Date:  2018-04-13       Impact factor: 91.245

6.  Efficacy and retention of silicone punctal plugs for treatment of dry eye in patients with and without ocular graft-versus-host-disease.

Authors:  Rohan Bir Singh; Ann Yung; Giulia Coco; Shruti Sinha; Thomas H Dohlman; Jia Yin; Reza Dana
Journal:  Ocul Surf       Date:  2020-07-30       Impact factor: 5.033

7.  Comparative Evaluation of Clinical Methods of Tear Film Stability Assessment: A Randomized Crossover Trial.

Authors:  Michael T M Wang; Jennifer P Craig
Journal:  JAMA Ophthalmol       Date:  2018-03-01       Impact factor: 7.389

8.  Comprehensive shotgun lipidomics of human meibomian gland secretions using MS/MSall with successive switching between acquisition polarity modes.

Authors:  Jianzhong Chen; Kelly K Nichols
Journal:  J Lipid Res       Date:  2018-10-02       Impact factor: 5.922

9.  Ophthalmology research in the UK's National Health Service: the structure and performance of the NIHR's Ophthalmology research portfolio.

Authors:  Sarah R Dawson; Emma Linton; Kris Beicher; Richard Gale; Praveen Patel; Faruque Ghanchi; Michael W Beresford; Vanessa Poustie; Usha Chakravarthy; Rupert R A Bourne
Journal:  Eye (Lond)       Date:  2018-11-20       Impact factor: 3.775

10.  Crosslinked hyaluronic acid with liposomes and crocin for management symptoms of dry eye disease caused by moderate meibomian gland dysfunction.

Authors:  José-María Sánchez-González; Concepción De-Hita-Cantalejo; María Carmen Sánchez-González
Journal:  Int J Ophthalmol       Date:  2020-09-18       Impact factor: 1.779

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.